Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors

Clinical trial NCT03689192 · COMPLETED

Trial details

NCT number: NCT03689192
Sponsor: Herlev Hospital
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Urothelial Carcinoma Malignant Melanoma Ovarian Cancer Colorectal Cancer Breast Cancer Squamous Cell Carcinoma of the Head and Neck Metastatic Cancer

Start date: 2018-12-17
Primary completion: 2022-01-19
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.